Business Monitor International calculates that pharmaceutical sales in Portugal reached 3.61 billion euros ($5.31 billion) in 2008. It calculates that the sales of prescription and over-the-counter medicines will see a constant annual growth rate (CAGR) of 2.79% in local currency terms. It notes that, as a result of the weakening euro, drug market expenditure in US dollar terms will experience a decline in 2009, 2010, 2011 and 2012, before reaching a value of $5.11 billion by 2013, equating to a CAGR of -0.77%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze